150:
phase, followed by a monthly maintenance phase that consists of injections for a period of 3–5 years. The build-up phase involves the patient being administered injections which contain increasing amounts of allergens about one to two times per week. The length of the build-up phase is dependent upon how often injections are administered, but normally ranges from three to six months. After the effective dose is reached, the maintenance phase is implemented, which varies depending upon an individual's response to the build-up phase.
360:(FDA) and the European Medicinal Agency (EMEA). The FDA currently allows individual allergists to create the formula for each dosage, whereas the EMEA requires treatment extracts to be prepared at manufacturing sites. The FDA has approved sublingual therapy through the use of tablets, but has not approved specific formulation. The EMEA has also approved sublingual therapy through both tablets and solution, and this administration now accounts for 45% of immunotherapy treatments.
380:
patients with allergies but also positively impacts the quality of life of them and others around them. As temperatures increase due to changing climates, pollen levels also increase. Allergies are becoming a more common problem among the public, which is why the science community advocates for allergen immunotherapy. Subcutaneous allergen immunotherapy, according to the scientific community, is an effective solution to allergies due to numerous positive studies.
2064:
42:
2076:
1348:
208:. It is not yet clear if there are any risk factors that might increase a person's susceptibility to these adverse effects. Sublingual immunotherapy appears to be better tolerated than subcutaneous immunotherapy and causes fewer side effects. The safety of sublingual immunotherapy has not been studied extensively in people with chronic
440:
protect mice from peanut-induced anaphylaxis. FAHF-2 was also well tolerated in a phase I study. While it is possible that omalizumab, FAHF-2 or other immunomodulatory agents alone might be able to treat dangerous allergies, combining these with OIT may be more effective and synergistic, warranting further investigation.
353:. The use of sublingual immunotherapy is supported by few allergy agencies in order to allow for more investigation to occur on its practical use. Oral immunotherapy is generally not recommended, however the EAACI recommends that this treatment only be administered at specialized centres with expert professionals.
332:
Sublingual immunotherapy drops are currently commercialized and used in most
European and South American countries, and in Australia and Asian countries. In most European countries, national regulations allow marketing of allergen products as "named patient preparations" (NPPs). In the United States,
316:
in 1911. Building on the observations of his predecessors
Bostock, Blackley and Dunbar, Noon noted that people with hay fever "sometimes become cured" and that this was possibly because they "have had the good fortune to develop an active immunity against the toxin." He hypothesized that by injecting
153:
When accounting for a person's age, type of allergen, and severity of allergy, there is a high probability that subcutaneous allergen immunotherapy may provide greater clinical and immunological responses than sublingual allergen immunotherapy. Compared to sublingual allergen immunotherapy, there are
307:
In the late 19th century and early 20th century, allergic conditions were increasingly attracting both medical attention (as an emerging public health problem) and scientific interest (aided by progress in biochemical techniques and the development of molecular and pathogenic theories). However, the
192:
Sublingual immunotherapy is used to treat allergic rhinitis, often from seasonal allergies, and is typically given in several doses over a 12-week period. It works best when given 12 weeks before the start of the pollen season. The first dose is given by a physician to monitor for any rare reactions
420:
One approach being studied is in altering the protein structure of the allergen to decrease immune response but still induce tolerance. Extensive heating of some foods can change the conformation of epitopes recognized by IgE antibodies. In fact, studies show that regular consumption of heated food
537:
Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, et al. (August 2006). "Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials".
379:
that treat symptoms, not the body's reaction. Communication about allergen immunotherapy is not described very often in the news media; it is usually only communicated by the science community. The scientific community describes allergen immunotherapy as a scientific solution that helps not only
164:
Allergen immunotherapy schedules include the "cluster" approach, which involves administering several doses sequentially in a single day; a "conventional" approach, which involves incrementally increasing the dose over approximately 15 weeks; and the "rush" approach, which involves administering
439:
was combined with high-dose milk oral immunotherapy and saw positive results. Several other trials are also currently being done combining omalizumab with OIT for a variety of food allergens. FAHF-2, a
Chinese herbal mixture, has shown positive effects on the immune system and has been shown to
149:
Subcutaneous immunotherapy (SCIT), also known as allergy shots, is the historical route of administration and consists of injections of allergen extract, which must be performed by a medical professional. Subcutaneous immunotherapy protocols generally involve weekly injections during a build-up
224:
Oral immunotherapy (OIT) involves feeding an allergic individual increasing amounts of a food allergen in order to raise the threshold which triggers a reaction. Long-term, many study participants still experienced mild allergic reactions or needed to regularly consume the allergen to maintain
196:
While a number of side effects have been associated with sublingual immunotherapy, serious adverse effects are very rare (about 1.4/100,000 doses), and there has not been a reported fatality. There have been a small number of reports of anaphylaxis. The majority of side effects are 'local' and
233:
for mitigating "allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts." It is the first drug approved for peanut allergies. It will not allow allergic people able to eat normal amounts of peanuts, but helps prevent allergies due to accidental eating.
188:
and asthma symptoms. This effectiveness, however, varies depending on the type of allergen. The strongest evidence for the efficacy of sublingual immunotherapy comes from studies that used grass allergens or mite allergens to alleviate allergic rhinitis symptoms; the evidence shows modest
333:
drop formulations have not yet received FDA approval, though off-label prescription is becoming common. In 2014, the FDA approved a once-daily sublingual tablet containing allergen extracts for the treatment of "hay fever" (allergic rhinitis with or without conjunctivitis).
168:
It is challenging to perform an adequate risk assessment on the use of subcutaneous allergen immunotherapy compared to other forms of allergen immunotherapy administration due to the variability of immunotherapy schedules and further research is required.
311:
The
British physicians Noon and Freeman were the first researchers to test pollen allergen immunotherapy in humans. Noon and Freeman, researchers at the Department of Therapeutic Inoculation at St. Mary's Hospital in London, published their findings in
135:
Discovered by
Leonard Noon and John Freeman in 1911, allergen immunotherapy is the only medicine known to tackle not only the symptoms but also the causes of respiratory allergies. A detailed diagnosis is necessary to identify the allergens involved.
421:
allergens can speed up allergy resolution. In one study, subjects allergic to milk were 16x more likely to develop complete milk tolerance compared to complete milk avoidance. Another approach regarding changes in protein is to change specific
101:
have found that injections of allergens under the skin are effective in the treatment of allergic rhinitis in children and in asthma. The benefits may last for years after treatment is stopped. It is generally safe and effective for
894:
van
Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, et al. (February 2000). "Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology".
254:
production. People are desensitized through the administration of escalating doses of allergen that gradually decreases the IgE-dominated response. The objective of immunotherapy is to direct the immune response away from
114:
against rhinitis and asthma, but it is less strong. In this form the allergen is given under the tongue and people often prefer it to injections. Immunotherapy is not recommended as a stand-alone treatment for asthma.
758:
Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Chelladurai Y, Segal JB, et al. (March 2014). "Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review".
454:
Studies have also been done to determine the efficacy of OIT for multiple allergens simultaneously. One study concluded that multi-OIT would be possible and relatively, though larger studies would be necessary.
1103:
Di Bona D, Plaia A, Scafidi V, Leto-Barone MS, Di
Lorenzo G (September 2010). "Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis".
298:
Reactivity is tested using oral food challenges or with skin prick tests. Phases 1 & 2 of sublingual immunotherapy are conducted in a supervised clinical setting. However, phase 3 can be done at home.
950:
Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C (May 2013). "Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison".
992:
Caminati M, Dama AR, Djuric I, Montagni M, Schiappoli M, Ridolo E, et al. (February 2015). "Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety".
432:
2 cells from responding to the allergens during treatment. For example, drugs that inhibit IgE-mediated signaling pathways can be used in addition to OIT to reduce immune response. In 1 trial, the
371:
Allergen immunotherapy is viewed as a beneficial way to curb allergies in the perspective of the media. It is seen where it can be covered by insurance and offer a more permanent solution than
413:
towards the allergen. However, there are still questions about longevity of tolerance after the study has ended. However, almost every study has excluded people with severe allergen-induced
341:
The use of subcutaneous immunotherapy for treatment of environmental-based allergies and asthma is well supported by the majority of national and international allergy groups such as the
161:
event. Subcutaneous allergen immunotherapy adverse events vary significantly depending on different allergenic extracts and the application of different allergen immunotherapy schedules.
393:
As of 2015, oral immunotherapy's balance of risk to benefit for food allergies was not well studied. As of 2011, OIT was under investigation as a treatment for a variety of common
242:
Transdermal immunotherapy (TDIT) involves skin-induced suppression via epicutaneous (EC) application of an antigen in order to raise the threshold which triggers a reaction.
229:
in patients who take it. Currently, the U.S. Food and Drug
Administration has not approved any oral immunotherapy agents for asthma. In January 2020, the FDA approved
132:
include mild or moderate skin or respiratory reactions. Severe side effects such as anaphylaxis during subcutaneous immunotherapy treatment are relatively uncommon.
477:
350:
346:
1662:
1303:
197:
usually resolve within a few days. They include swelling of the mouth, tongue or lip, throat irritation, nausea, abdominal pain, vomiting, diarrhea,
1189:
1329:
1276:
1304:
U.S. Department of Health and Human
Services. National Institutes of Health - National Heart Lung and Blood Institute (December 2020).
451:
release, it may one day be possible to take a pill containing nanoparticles that will modulate dosing, requiring fewer office visits.
1800:
730:
17:
1305:
193:
or anaphylaxis. Subsequent doses can be taken at home which makes this a convenient alternative to subcutaneous immunotherapy.
250:
In desensitization immunotherapy the aim is to induce or restore tolerance to the allergen by reducing its tendency to induce
1765:
Cox L, Jacobsen L (December 2009). "Comparison of allergen immunotherapy practice patterns in the United States and Europe".
180:
immunotherapy involves putting drops or a tablet of allergen extracts under the tongue, which are then absorbed through the
157:
It is possible, but rare (1/2.5 million), that people undergoing subcutaneous allergen immunotherapy may experience a fatal
363:
The FDA advisory board has supported the use of AR101, an oral immunotherapy, for patients with peanut allergies in 2019.
121:
during sublingual immunotherapy treatment are usually local and mild and can often be eliminated by adjusting the dosage.
481:
268:
225:
desensitivity. Additionally, oral immunotherapy is known to have an increased risk in the probability of needing
263:, thereby encouraging the body to produce fewer IgE antibodies and more CD4+ T regulatory cells that secrete
1371:
1146:
Pepper AN, CalderĂłn MA, Casale TB (January 2017). "Sublingual
Immunotherapy for the Polyallergic Patient".
357:
629:
Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, et al. (December 2009).
937:"Allergy Shots (Immunotherapy) | AAAAI." The American Academy of Allergy, Asthma & Immunology, 2019,
2054:
1687:
410:
342:
1395:
317:
people with hay fever with small amounts of a pollen "toxin", a state of immunity could be achieved.
177:
1420:
Szczepanik M, Majewska-Szczepanik M (2016). "Transdermal immunotherapy: Past, present and future".
226:
111:
1980:
BĂ©gin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, et al. (January 2014).
428:
Another approach to improving oral immunotherapy is to change the immune environment to prevent T
107:
1825:
Barnes CS, Alexis NE, Bernstein JA, Cohn JR, Demain JG, Horner E, et al. (March 15, 2013).
1052:
Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, et al. (March 2014).
2101:
1619:"Further observation on the treatment of hay-fever by hypodermic inoculation of pollen vaccine"
803:
230:
128:
Potential side effects related to subcutaneous immunotherapy treatment for asthma and allergic
1717:
Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, et al. (September 2015).
506:
Abramson MJ, Puy RM, Weiner JM (August 2010). "Injection allergen immunotherapy for asthma".
1539:"Oral and sublingual immunotherapy for food allergy: current progress and future directions"
2096:
287:
8:
433:
129:
425:
in the protein to decrease recognition of the allergen by allergen-specific antibodies.
110:, allergic forms of asthma, and stinging insects. The evidence also supports the use of
2008:
1981:
1957:
1932:
1859:
1826:
1563:
1538:
1505:
1478:
1445:
1254:
1238:
1080:
1053:
1017:
920:
876:
784:
668:
655:
630:
599:
574:
1778:
1634:
1603:
551:
2013:
1982:"Safety and feasibility of oral immunotherapy to multiple allergens for food allergy"
1962:
1913:
1905:
1864:
1846:
1782:
1740:
1568:
1510:
1437:
1246:
1171:
1163:
1121:
1085:
1009:
967:
912:
908:
868:
860:
825:
776:
709:
660:
646:
604:
555:
519:
447:) is a field of development that can be used for OIT. With the potential to modulate
260:
103:
1827:"Climate Change and Our Environment: The Effect on Respiratory and Allergic Disease"
1258:
1021:
924:
880:
672:
2003:
1993:
1952:
1944:
1895:
1854:
1838:
1774:
1730:
1630:
1599:
1558:
1550:
1500:
1490:
1449:
1429:
1284:
1228:
1155:
1113:
1075:
1065:
1001:
959:
904:
852:
815:
788:
768:
699:
650:
642:
594:
590:
586:
547:
515:
511:
279:
275:
256:
251:
209:
2080:
1900:
1883:
1433:
1054:"Sublingual immunotherapy: World Allergy Organization position paper 2013 update"
1005:
856:
573:
Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S (January 2007).
2068:
1842:
1735:
1718:
1159:
1117:
963:
820:
398:
376:
264:
202:
1948:
1554:
2090:
1909:
1850:
1352:
1167:
864:
444:
372:
98:
1428:(4). US National Library of Medicine National Institutes of Health: 773–81.
1365:
1289:
2017:
1998:
1966:
1917:
1868:
1786:
1744:
1572:
1514:
1495:
1441:
1250:
1175:
1125:
1089:
1013:
971:
916:
872:
829:
780:
713:
664:
631:"Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009"
608:
559:
523:
402:
394:
213:
1070:
125:
during sublingual immunotherapy treatment has occurred on rare occasions.
893:
414:
406:
184:. Sublingual immunotherapy has been demonstrated to be effective against
181:
158:
122:
118:
91:. Immunotherapy involves exposing people to larger and larger amounts of
1242:
62:
1196:. American Academy of Allergy, Asthma & Immunology. 4 February 2020
804:"One hundred years of allergen immunotherapy: Time to ring the changes"
772:
436:
422:
1330:"FDA approves first drug for treatment of peanut allergy for children"
1277:"First peanut allergy treatment gains backing from FDA advisory panel"
1233:
1216:
704:
687:
536:
321:
283:
198:
2034:
1618:
1587:
2063:
757:
320:
Allergen immunotherapy was part of mainstream medical practice for
290:, two cell types that are large contributors to allergic reaction.
185:
92:
1647:
Bostock J. "Case of a periodical affection of the eyes and chest.
1801:"With a litter of tactics, scientists work to tame cat allergies"
1663:"Allergy Drops Under the Tongue May be Fine Alternative to Shots"
1351:
This article incorporates text from this source, which is in the
575:"Allergen injection immunotherapy for seasonal allergic rhinitis"
448:
356:
Subcutaneous immunotherapy is both approved and regulated by the
274:
Oral immunotherapy also creates an increase in allergen-specific
84:
1051:
1396:"The FDA has approved the first drug to treat peanut allergies"
1306:"Can Immunotherapy Help with the Treatment of Allergic Asthma?"
165:
incremental doses at intervals of 15–60 minutes over 1–3 days.
88:
1979:
1102:
949:
1419:
308:
many and varied treatment approaches were very unscientific.
205:
41:
628:
572:
1148:
The Journal of Allergy and Clinical Immunology: In Practice
1831:
The Journal of Allergy and Clinical Immunology in Practice
991:
843:
Sastre J (2013). "Molecular diagnosis and immunotherapy".
1824:
1884:"Allergy immunotherapy: the future of allergy treatment"
336:
154:
no significant differences observed in quality of life.
2040:
2046:
1716:
95:
in an attempt to change the immune system's response.
2052:
2041:"American College of Allergy, Asthma, and Immunology"
2035:"American Academy of Allergy, Asthma, and Immunology"
1194:
American Academy of Allergy, Asthma, & Immunology
271:, which skews the response away from IgE production.
1479:"Oral and sublingual immunotherapy for food allergy"
1214:
1145:
347:
European Academy of Allergy and Clinical Immunology
1719:"International consensus on allergy immunotherapy"
845:Current Opinion in Allergy and Clinical Immunology
351:American Academy of Allergy, Asthma and Immunology
1881:
1536:
505:
2088:
1933:"Oral desensitization for food hypersensitivity"
1537:Moran TP, Vickery BP, Burks AW (December 2013).
1462:Janeway's Immunobiology, 8th Edition, Chapter 14
1937:Immunology and Allergy Clinics of North America
278:antibodies and a decrease in allergen-specific
1723:The Journal of Allergy and Clinical Immunology
1274:
1106:The Journal of Allergy and Clinical Immunology
952:The Journal of Allergy and Clinical Immunology
345:, Canadian Society of Allergy and Immunology,
27:Medical treatment for environmental allergies
1930:
1588:"Prophylactic inoculation against hay fever"
1215:Feuille E, Nowak-Wegrzyn A (June 30, 2016).
624:
622:
620:
618:
472:
470:
468:
1882:Larsen JN, Broge L, Jacobi H (2016-01-01).
1764:
1616:
1532:
1530:
1528:
1526:
1524:
1413:
1047:
1045:
1043:
1041:
1039:
1037:
1035:
1033:
1031:
987:
985:
983:
981:
579:The Cochrane Database of Systematic Reviews
508:The Cochrane Database of Systematic Reviews
83:, is a medical treatment for environmental
2047:"American Board of Allergy and Immunology"
1767:Annals of Allergy, Asthma & Immunology
1585:
945:
943:
540:Annals of Allergy, Asthma & Immunology
501:
499:
40:
2007:
1997:
1956:
1899:
1858:
1734:
1562:
1504:
1494:
1472:
1470:
1468:
1288:
1232:
1190:"The Current State of Oral Immunotherapy"
1079:
1069:
819:
703:
654:
615:
598:
465:
2049:American Board of Allergy and Immunology
1986:Allergy, Asthma, and Clinical Immunology
1521:
1028:
978:
530:
366:
1680:
1476:
1275:Couzin-Frankel J (September 13, 2019).
1217:"Oral Immunotherapy for Food Allergies"
940:
496:
14:
2089:
1931:Land MH, Kim EH, Burks AW (May 2011).
1483:The World Allergy Organization Journal
1465:
1322:
1058:The World Allergy Organization Journal
842:
801:
685:
327:
245:
2043:information and articles of interest.
2037:information and articles of interest.
1760:
1758:
1756:
1754:
1712:
1710:
1708:
1660:
1270:
1268:
1141:
1139:
1137:
1135:
388:
358:American Food and Drug Administration
337:Recognition by international agencies
1924:
1221:Annals of Nutrition & Metabolism
1182:
994:Expert Review of Clinical Immunology
753:
751:
725:
723:
1208:
409:. Studies involving OIT have shown
55:Desensitization, hypo-sensitization
24:
1751:
1705:
1358:
1265:
1132:
282:antibodies, as well as diminished
25:
2113:
2028:
748:
731:"Sublingual Immunotherapy (SLIT)"
720:
686:Rank MA, Li JT (September 2007).
2074:
2062:
1346:
1336:(Press release). 31 January 2020
909:10.1034/j.1398-9995.2000.00526.x
647:10.1111/j.1398-9995.2009.02309.x
480:. April 22, 2015. Archived from
443:In addition, various adjuvants (
1973:
1875:
1818:
1793:
1773:(6): 451–59, quiz 459–61, 495.
1654:
1641:
1610:
1579:
1456:
1388:
1334:US Food and Drug Administration
1297:
1096:
931:
887:
836:
144:
795:
679:
591:10.1002/14651858.CD001936.pub2
566:
516:10.1002/14651858.CD001186.pub2
237:
13:
1:
1779:10.1016/S1081-1206(10)60259-1
1635:10.1016/s0140-6736(01)40417-x
1604:10.1016/s0140-6736(00)78276-6
1543:Current Opinion in Immunology
552:10.1016/S1081-1206(10)60004-X
458:
172:
1901:10.1016/j.drudis.2015.07.010
1434:10.1016/j.pharep.2016.04.004
1372:Food and Drug Administration
1006:10.1586/1744666X.2015.988143
857:10.1097/ACI.0b013e328364f4c6
7:
1688:"Approval Letter - ORALAIR"
1366:"Palforzia Approval Letter"
383:
293:
87:(such as insect bites) and
46:An Alutard SQ injection kit
10:
2118:
1843:10.1016/j.jaip.2012.07.002
1736:10.1016/j.jaci.2015.04.047
1617:Freeman J, Noon L (1911).
1586:Noon L, Cantab BC (1911).
1160:10.1016/j.jaip.2016.06.019
1118:10.1016/j.jaci.2010.06.013
964:10.1016/j.jaci.2013.02.013
821:10.1016/j.jaci.2010.11.032
343:World Allergy Organization
302:
1949:10.1016/j.iac.2011.02.008
1661:Shute N (27 March 2013).
1555:10.1016/j.coi.2013.07.011
59:
51:
39:
34:
1477:Le UH, Burks AW (2014).
688:"Allergen immunotherapy"
478:"Allergen Immunotherapy"
324:treatment in the 1930s.
139:
112:sublingual immunotherapy
18:Sublingual immunotherapy
1422:Pharmacological Reports
1290:10.1126/science.aaz5008
692:Mayo Clinic Proceedings
219:
108:allergic conjunctivitis
1999:10.1186/1710-1492-10-1
1496:10.1186/1939-4551-7-35
808:J Allergy Clin Immunol
73:Allergen immunotherapy
35:Allergen immunotherapy
1071:10.1186/1939-4551-7-6
367:Science communication
1888:Drug Discovery Today
735:ACAAI Public Website
484:on 9 September 2016
434:monoclonal antibody
328:Society and culture
246:Mechanism of action
186:rhinoconjunctivitis
182:lining of the mouth
130:rhinoconjunctivitis
773:10.1002/lary.24295
641:(Suppl 91): 1–59.
389:Oral immunotherapy
81:hypo-sensitization
1943:(2): 367–76, xi.
1376:. 31 January 2020
1234:10.1159/000445391
802:Durham S (2010).
705:10.4065/82.9.1119
261:cellular immunity
104:allergic rhinitis
70:
69:
16:(Redirected from
2109:
2079:
2078:
2077:
2067:
2066:
2058:
2022:
2021:
2011:
2001:
1977:
1971:
1970:
1960:
1928:
1922:
1921:
1903:
1879:
1873:
1872:
1862:
1822:
1816:
1815:
1813:
1812:
1797:
1791:
1790:
1762:
1749:
1748:
1738:
1714:
1703:
1702:
1700:
1698:
1684:
1678:
1677:
1675:
1673:
1658:
1652:
1645:
1639:
1638:
1614:
1608:
1607:
1598:(4580): 1572–3.
1583:
1577:
1576:
1566:
1534:
1519:
1518:
1508:
1498:
1474:
1463:
1460:
1454:
1453:
1417:
1411:
1410:
1408:
1407:
1392:
1386:
1385:
1383:
1381:
1362:
1356:
1350:
1349:
1345:
1343:
1341:
1326:
1320:
1319:
1317:
1315:
1310:
1301:
1295:
1294:
1292:
1272:
1263:
1262:
1236:
1212:
1206:
1205:
1203:
1201:
1186:
1180:
1179:
1143:
1130:
1129:
1100:
1094:
1093:
1083:
1073:
1049:
1026:
1025:
989:
976:
975:
947:
938:
935:
929:
928:
891:
885:
884:
840:
834:
833:
823:
799:
793:
792:
761:The Laryngoscope
755:
746:
745:
743:
742:
727:
718:
717:
707:
683:
677:
676:
658:
626:
613:
612:
602:
570:
564:
563:
534:
528:
527:
503:
494:
493:
491:
489:
474:
257:humoral immunity
210:immunodeficiency
75:, also known as
63:edit on Wikidata
44:
32:
31:
21:
2117:
2116:
2112:
2111:
2110:
2108:
2107:
2106:
2087:
2086:
2085:
2075:
2073:
2061:
2053:
2031:
2026:
2025:
1978:
1974:
1929:
1925:
1880:
1876:
1823:
1819:
1810:
1808:
1799:
1798:
1794:
1763:
1752:
1715:
1706:
1696:
1694:
1686:
1685:
1681:
1671:
1669:
1659:
1655:
1649:Med Chir Trans.
1646:
1642:
1629:(4594): 814–7.
1615:
1611:
1584:
1580:
1535:
1522:
1475:
1466:
1461:
1457:
1418:
1414:
1405:
1403:
1394:
1393:
1389:
1379:
1377:
1364:
1363:
1359:
1347:
1339:
1337:
1328:
1327:
1323:
1313:
1311:
1308:
1302:
1298:
1273:
1266:
1213:
1209:
1199:
1197:
1188:
1187:
1183:
1144:
1133:
1101:
1097:
1050:
1029:
990:
979:
948:
941:
936:
932:
892:
888:
841:
837:
800:
796:
756:
749:
740:
738:
729:
728:
721:
684:
680:
627:
616:
585:(1): CD001936.
571:
567:
535:
531:
510:(8): CD001186.
504:
497:
487:
485:
476:
475:
466:
461:
431:
411:desensitization
391:
386:
369:
339:
330:
305:
296:
248:
240:
222:
175:
147:
142:
77:desensitization
66:
47:
28:
23:
22:
15:
12:
11:
5:
2115:
2105:
2104:
2099:
2084:
2083:
2071:
2051:
2050:
2044:
2038:
2030:
2029:External links
2027:
2024:
2023:
1972:
1923:
1874:
1837:(2): 137–141.
1817:
1792:
1750:
1704:
1679:
1653:
1640:
1609:
1578:
1520:
1464:
1455:
1412:
1387:
1357:
1321:
1296:
1264:
1207:
1181:
1131:
1095:
1027:
977:
939:
930:
886:
851:(6): 646–650.
835:
794:
747:
719:
698:(9): 1119–23.
678:
614:
565:
529:
495:
463:
462:
460:
457:
429:
395:food allergies
390:
387:
385:
382:
377:nasal steroids
373:antihistamines
368:
365:
338:
335:
329:
326:
304:
301:
295:
292:
247:
244:
239:
236:
221:
218:
174:
171:
146:
143:
141:
138:
68:
67:
60:
57:
56:
53:
49:
48:
45:
37:
36:
26:
9:
6:
4:
3:
2:
2114:
2103:
2102:Immunotherapy
2100:
2098:
2095:
2094:
2092:
2082:
2072:
2070:
2065:
2060:
2059:
2056:
2048:
2045:
2042:
2039:
2036:
2033:
2032:
2019:
2015:
2010:
2005:
2000:
1995:
1991:
1987:
1983:
1976:
1968:
1964:
1959:
1954:
1950:
1946:
1942:
1938:
1934:
1927:
1919:
1915:
1911:
1907:
1902:
1897:
1893:
1889:
1885:
1878:
1870:
1866:
1861:
1856:
1852:
1848:
1844:
1840:
1836:
1832:
1828:
1821:
1806:
1802:
1796:
1788:
1784:
1780:
1776:
1772:
1768:
1761:
1759:
1757:
1755:
1746:
1742:
1737:
1732:
1729:(3): 556–68.
1728:
1724:
1720:
1713:
1711:
1709:
1693:
1689:
1683:
1668:
1664:
1657:
1650:
1644:
1636:
1632:
1628:
1624:
1620:
1613:
1605:
1601:
1597:
1593:
1589:
1582:
1574:
1570:
1565:
1560:
1556:
1552:
1548:
1544:
1540:
1533:
1531:
1529:
1527:
1525:
1516:
1512:
1507:
1502:
1497:
1492:
1488:
1484:
1480:
1473:
1471:
1469:
1459:
1451:
1447:
1443:
1439:
1435:
1431:
1427:
1423:
1416:
1401:
1397:
1391:
1375:
1373:
1367:
1361:
1354:
1353:public domain
1335:
1331:
1325:
1307:
1300:
1291:
1286:
1282:
1278:
1271:
1269:
1260:
1256:
1252:
1248:
1244:
1240:
1235:
1230:
1226:
1222:
1218:
1211:
1195:
1191:
1185:
1177:
1173:
1169:
1165:
1161:
1157:
1153:
1149:
1142:
1140:
1138:
1136:
1127:
1123:
1119:
1115:
1112:(3): 558–66.
1111:
1107:
1099:
1091:
1087:
1082:
1077:
1072:
1067:
1063:
1059:
1055:
1048:
1046:
1044:
1042:
1040:
1038:
1036:
1034:
1032:
1023:
1019:
1015:
1011:
1007:
1003:
1000:(2): 233–45.
999:
995:
988:
986:
984:
982:
973:
969:
965:
961:
958:(5): 1361–6.
957:
953:
946:
944:
934:
926:
922:
918:
914:
910:
906:
903:(2): 116–34.
902:
898:
890:
882:
878:
874:
870:
866:
862:
858:
854:
850:
846:
839:
831:
827:
822:
817:
813:
809:
805:
798:
790:
786:
782:
778:
774:
770:
767:(3): 616–27.
766:
762:
754:
752:
736:
732:
726:
724:
715:
711:
706:
701:
697:
693:
689:
682:
674:
670:
666:
662:
657:
652:
648:
644:
640:
636:
632:
625:
623:
621:
619:
610:
606:
601:
596:
592:
588:
584:
580:
576:
569:
561:
557:
553:
549:
545:
541:
533:
525:
521:
517:
513:
509:
502:
500:
483:
479:
473:
471:
469:
464:
456:
452:
450:
446:
445:nanoparticles
441:
438:
435:
426:
424:
418:
416:
412:
408:
404:
400:
396:
381:
378:
374:
364:
361:
359:
354:
352:
348:
344:
334:
325:
323:
318:
315:
309:
300:
291:
289:
285:
281:
277:
272:
270:
266:
262:
258:
253:
243:
235:
232:
228:
217:
215:
211:
207:
204:
200:
194:
190:
189:improvement.
187:
183:
179:
170:
166:
162:
160:
155:
151:
137:
133:
131:
126:
124:
120:
116:
113:
109:
105:
100:
99:Meta-analyses
96:
94:
90:
86:
82:
78:
74:
64:
58:
54:
50:
43:
38:
33:
30:
19:
1989:
1985:
1975:
1940:
1936:
1926:
1894:(1): 26–37.
1891:
1887:
1877:
1834:
1830:
1820:
1809:. Retrieved
1807:. 2020-02-13
1805:Science News
1804:
1795:
1770:
1766:
1726:
1722:
1695:. Retrieved
1691:
1682:
1670:. Retrieved
1666:
1656:
1651:1819;10:161.
1648:
1643:
1626:
1622:
1612:
1595:
1591:
1581:
1549:(6): 781–7.
1546:
1542:
1486:
1482:
1458:
1425:
1421:
1415:
1404:. Retrieved
1402:. 2020-02-04
1400:Science News
1399:
1390:
1378:. Retrieved
1369:
1360:
1338:. Retrieved
1333:
1324:
1314:November 18,
1312:. Retrieved
1299:
1280:
1224:
1220:
1210:
1198:. Retrieved
1193:
1184:
1154:(1): 41–45.
1151:
1147:
1109:
1105:
1098:
1061:
1057:
997:
993:
955:
951:
933:
900:
896:
889:
848:
844:
838:
811:
807:
797:
764:
760:
739:. Retrieved
737:. 2015-01-05
734:
695:
691:
681:
638:
634:
582:
578:
568:
546:(2): 141–8.
543:
539:
532:
507:
486:. Retrieved
482:the original
453:
442:
427:
419:
392:
370:
362:
355:
340:
331:
319:
313:
310:
306:
297:
273:
249:
241:
223:
195:
191:
176:
167:
163:
159:anaphylactic
156:
152:
148:
145:Subcutaneous
134:
127:
119:Side effects
117:
97:
80:
76:
72:
71:
29:
2097:Allergology
1380:13 February
423:amino acids
415:anaphylaxis
259:and toward
238:Transdermal
227:epinephrine
216:disorders.
123:Anaphylaxis
52:Other names
2091:Categories
1811:2020-11-15
1406:2020-02-13
1340:31 January
814:(1): 3–7.
741:2018-11-05
459:References
437:omalizumab
397:including
349:, and the
314:The Lancet
284:mast cells
214:autoimmune
178:Sublingual
173:Sublingual
1910:1359-6446
1851:2213-2198
1489:(1): 35.
1227:: 18–31.
1200:1 October
1168:2213-2198
865:1528-4050
322:hay fever
288:basophils
231:Palforzia
199:heartburn
93:allergens
85:allergies
2081:Medicine
2018:24428859
1992:(1): 1.
1967:21530825
1918:26327511
1869:23687635
1787:20084837
1745:26162571
1573:23972904
1515:25709745
1442:27236747
1259:21655226
1251:27355816
1243:48508034
1176:27452888
1126:20674964
1090:24679069
1064:(1): 6.
1022:32045539
1014:25484197
972:23557834
925:39942935
917:10726726
881:43357832
873:24071714
830:21211638
781:23832632
714:17803880
673:10420738
665:20041860
609:17253469
560:16937742
524:20687065
384:Research
294:Protocol
2069:Biology
2055:Portals
2009:3913318
1958:3111958
1860:3654689
1697:20 June
1672:22 July
1564:3935613
1506:4325942
1450:9714708
1281:Science
1081:3983904
897:Allergy
789:8796632
656:3488881
635:Allergy
600:7017974
488:15 June
449:antigen
399:peanuts
303:History
2016:
2006:
1965:
1955:
1916:
1908:
1867:
1857:
1849:
1785:
1743:
1623:Lancet
1592:Lancet
1571:
1561:
1513:
1503:
1448:
1440:
1257:
1249:
1241:
1174:
1166:
1124:
1088:
1078:
1020:
1012:
970:
923:
915:
879:
871:
863:
828:
787:
779:
712:
671:
663:
653:
607:
597:
558:
522:
405:, and
203:uvular
201:, and
89:asthma
1446:S2CID
1374:(FDA)
1370:U.S.
1309:(PDF)
1255:S2CID
1239:JSTOR
1018:S2CID
921:S2CID
877:S2CID
785:S2CID
669:S2CID
269:TGF-β
265:IL-10
206:edema
140:Types
61:[
2014:PMID
1963:PMID
1914:PMID
1906:ISSN
1865:PMID
1847:ISSN
1783:PMID
1741:PMID
1699:2017
1674:2013
1569:PMID
1511:PMID
1438:PMID
1382:2020
1342:2020
1316:2022
1247:PMID
1202:2023
1172:PMID
1164:ISSN
1122:PMID
1086:PMID
1010:PMID
968:PMID
913:PMID
869:PMID
861:ISSN
826:PMID
777:PMID
710:PMID
661:PMID
605:PMID
583:2007
556:PMID
520:PMID
490:2015
407:eggs
403:milk
286:and
276:IgG4
267:and
220:Oral
2004:PMC
1994:doi
1953:PMC
1945:doi
1896:doi
1855:PMC
1839:doi
1775:doi
1771:103
1731:doi
1727:136
1692:FDA
1667:NPR
1631:doi
1600:doi
1596:177
1559:PMC
1551:doi
1501:PMC
1491:doi
1430:doi
1285:doi
1229:doi
1156:doi
1114:doi
1110:126
1076:PMC
1066:doi
1002:doi
960:doi
956:131
905:doi
853:doi
816:doi
812:127
769:doi
765:124
700:doi
651:PMC
643:doi
595:PMC
587:doi
548:doi
512:doi
375:or
280:IgE
252:IgE
212:or
79:or
2093::
2012:.
2002:.
1990:10
1988:.
1984:.
1961:.
1951:.
1941:31
1939:.
1935:.
1912:.
1904:.
1892:21
1890:.
1886:.
1863:.
1853:.
1845:.
1833:.
1829:.
1803:.
1781:.
1769:.
1753:^
1739:.
1725:.
1721:.
1707:^
1690:.
1665:.
1625:.
1621:.
1594:.
1590:.
1567:.
1557:.
1547:25
1545:.
1541:.
1523:^
1509:.
1499:.
1485:.
1481:.
1467:^
1444:.
1436:.
1426:68
1424:.
1398:.
1368:.
1332:.
1283:.
1279:.
1267:^
1253:.
1245:.
1237:.
1225:68
1223:.
1219:.
1192:.
1170:.
1162:.
1150:.
1134:^
1120:.
1108:.
1084:.
1074:.
1060:.
1056:.
1030:^
1016:.
1008:.
998:11
996:.
980:^
966:.
954:.
942:^
919:.
911:.
901:55
899:.
875:.
867:.
859:.
849:13
847:.
824:.
810:.
806:.
783:.
775:.
763:.
750:^
733:.
722:^
708:.
696:82
694:.
690:.
667:.
659:.
649:.
639:64
637:.
633:.
617:^
603:.
593:.
581:.
577:.
554:.
544:97
542:.
518:.
498:^
467:^
417:.
401:,
106:,
2057::
2020:.
1996::
1969:.
1947::
1920:.
1898::
1871:.
1841::
1835:1
1814:.
1789:.
1777::
1747:.
1733::
1701:.
1676:.
1637:.
1633::
1627:2
1606:.
1602::
1575:.
1553::
1517:.
1493::
1487:7
1452:.
1432::
1409:.
1384:.
1355:.
1344:.
1318:.
1293:.
1287::
1261:.
1231::
1204:.
1178:.
1158::
1152:5
1128:.
1116::
1092:.
1068::
1062:7
1024:.
1004::
974:.
962::
927:.
907::
883:.
855::
832:.
818::
791:.
771::
744:.
716:.
702::
675:.
645::
611:.
589::
562:.
550::
526:.
514::
492:.
430:H
65:]
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
